CIK 0001699031 · Non-accelerated filer<br>Emerging growth company
GRAIL, Inc.
Sign in to watch- Ticker
- GRAL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863673636
- Phone
- (833) 694-2553
- Business address
- 250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
- Former names
- GRAIL, LLC
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Grant or award Director acquired 396 shares (grant or award)
- 4 Grant or award Director acquired 408 shares (grant or award)
- 4 Grant or award Director acquired 631 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 45,806 shares at $49.92 ($2,286,526)
- 4 Open-market sale Chief Executive Officer sold 123,502 shares at $49.92 ($6,164,923)
- 4 Open-market sale President sold 61,665 shares at $49.92 ($3,078,169)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 4 Open-market sale Chief Financial Officer sold 3,147 shares at an average $48.96 ($154,062)
- 4 Open-market sale President sold 3,627 shares at an average $48.86 ($177,227)
- 4 Open-market sale Chief Executive Officer sold 8,441 shares at an average $48.48 ($409,246)
Page 3 of 14 · 267 filings